13F-HR filed by Lion Point Capital, LP
Lion Point Capital, LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 39 holding rows worth $19,323,534.
- Accession
- 0001013594-26-000252
- Filer
- CIK 1643354
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 39 entries on the cover page, a total value of $19,323,534 stated on the cover page (in dollars after the unit check, H1), rows summing to $19,323,534 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 755,000 | $1,525,100 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 4,450 | $1,311,593 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 67,500 | $889,650 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 112,434 | $865,742 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 465,000 | $850,950 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 62,000 | $835,140 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 21,400 | $826,896 | dollars as filed | |
| GERON CORP | 374163103 | COM | 578,000 | $762,960 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 36,000 | $756,360 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 128,650 | $750,030 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P106 | COM | 2,202,854 | $672,752 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 8,100 | $643,221 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 28,500 | $613,320 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 51,700 | $583,693 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 500,000 | $480,250 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 46,000 | $477,940 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R201 | CMN | 31,570 | $469,762 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 58,000 | $400,200 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 42,000 | $391,440 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 26,600 | $383,040 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 5,000 | $382,450 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 10,500 | $381,045 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 41,500 | $374,745 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 5,500 | $366,025 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 18,000 | $352,080 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 14,700 | $351,771 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 13,500 | $349,380 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 27,700 | $344,865 | dollars as filed | |
| AZENTA INC | 114340102 | COM | 9,700 | $322,622 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 86,000 | $301,860 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 19,000 | $262,200 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 9,100 | $225,817 | dollars as filed | |
| INNOVIVA INC | 45781M101 | COM | 8,200 | $163,918 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 5,250 | $152,460 | dollars as filed | |
| INNATE PHARMA S A | 45781K204 | SPONSORED ADS | 81,151 | $142,014 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 35,000 | $140,700 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 10,200 | $129,540 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 1,000 | $87,110 | dollars as filed | |
| MERSANA THERAPEUTICS INC | 59045L205 | COM | 100 | $2,893 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-26-000252 | this filing | 2026-02-17 | acceptance time not in the bulk data set |